Opinion
Read expert opinions and analysis on policy, markets, and culture in the cannabis industry.
Opinion · page 6
- Opinion
Switzerland’s ‘Pragmatic Not Political’ Approach To Cannabis Reform Should Set Precedent
Last week saw the launch of ZüriCan, Switzerland’s second cannabis pilot set to give over 2000 Zurich inhabitants legal access to adult-use cannabis.
- Opinion
What is Next After the German House Passes Cannabis Reform?
Last week, Germany took the first step towards wholesale cannabis legalisation after the federal cabinet waved through the long-awaited draft bill for Pillar 1 of its strategy.
- Opinion
The Growing Need for Medicinal Cannabis is a Reality in Spain That Cannot be Avoided
Ahead of the snap Spanish election this weekend, Chief Executive Officer of Linneo Health Don Bellamy lays out the frustrating situation for thousands of patients who are forced to turn to the black market despite a medical cannabis framework being ‘within reach’.
- Opinion
‘Cannabis Is A Very Healthy Business And Companies Can Do Very Well’, But A ‘Perspective Shift’ Needs To Take Place
While many in the industry continue to extol the commercial opportunities of the cannabis industry in order to try and turn the dial on government and institutional support, FoxNRTH’s Principal Chris Murray believes in a different approach.
- Opinion
‘Cannabis Is A Very Healthy Business And Companies Can Do Very Well’, But A ‘Perspective Shift’ Needs To Take Place
While many in the industry continue to extol the commercial opportunities of the cannabis industry in order to try and turn the dial on government and institutional support, FoxNRTH’s Principal Chris Murray believes in a different approach.
- Opinion
‘Enabling Medical Cannabis To Grow Properly In Europe Is The Real Opportunity’ – Avicanna
In the run-up to Cannabis Europa 2023, Prohibition Partners’ CEO Stephen Murphy caught up with Aras Azadian, co-founder and CEO of Avicanna. Stephen and Aras discuss Avicanna’s landmark partnership with Canadian pharmacy giant Shoppers Drug Mart, alongside reviewing differences between the Canadian and European industries, patient access and affordability and what to look forward to in the emerging European market.
- Opinion
The UK ‘Should Ultimately Be Leading’ The World In Compassionate Clinical Cannabis Trials
Robin Emerson, CEO of the Jorja Emerson Centre, was introduced to the life changing impact medical cannabis can have after his daughter was diagnosed with a chromosome disorder which causes a severe form of epilepsy.
- Opinion
New York Cannabis Retailers Left In Limbo – What Should Happen Next?
THE rollout of New York’s recreational cannabis market has been anything but smooth. Earlier this year, a federal court upheld an injunction blocking the state’s cannabis dispensary rollout in five regions.
- Opinion
To Stop UK Drug Policy Being Based On ‘Politics And Emotions’ We Need A ‘Proper, Rational Evidence-Based Conversation’ Around Cannabis
With a general election looming, drugs policy in the UK could soon become a hot button issue for both politicians and the public.
- Opinion
The Gradual Transition From ‘Prosecution To Protection’ Is A ‘Huge Step Forward For The EU As A Whole’
Last July, five members of the European Parliament from different political groups and different EU Member States came together to create an interest group of MEPs who support human rights-based policies related to personal use of cannabis.
- Opinion
MHRA Clarification Is A Step In The Right Direction, Says CIC
IN November 2022, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) released new detailed guidelines for medical cannabis companies operating in the UK, providing a step-by-step plan for those ‘that do not already hold the necessary authorisations’ to begin producing cannabis-based medicinal products and APIs.
- Hemp Industry
A ‘Momentous Occasion’ For Hemp With Its Multiple Attributes Recognised At The United Nations
After 60-plus years of negativity and prohibition the tide has turned for hemp at the highest levels of global governance, explain Lorenza Romanese, Managing Director and Francesco Mirizzi, Senior Policy Advisor, at the European Industrial Hemp Association.
